THERACRYF PLC
TCF | IL
Overview
Corporate Details
- ISIN(s):
- GB00BMVN2C70 (+2 more)
- LEI:
- 213800NO3E6TSTQO8K20
- Country:
- United Kingdom
- Address:
- SUITE 24G13 - BLOCK 24, SK10 4TG NETHER ALDERLEY
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
TheraCryf plc develops innovative therapeutics for oncology and behavioral brain disorders. Its strategy is to partner with larger pharma companies after generating compelling data. Key assets include SFX-01 and novel compounds targeting brain health.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-16 17:10 |
Report Publication Announcement
Notice of AGM
|
English | 13.0 KB | |
| 2025-06-10 13:32 |
Investor Presentation
Ox-1 Investor Presentation
|
English | 11.6 KB | |
| 2025-06-03 08:00 |
Earnings Release
Final results for year to 31 March 2025
|
English | 235.9 KB | |
| 2025-05-23 08:14 |
Earnings Release
Notice of Results and Ox-1 presentation
|
English | 12.5 KB | |
| 2025-05-22 13:43 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 52.1 KB | |
| 2025-05-16 14:00 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 23.2 KB | |
| 2025-03-19 13:10 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 23.3 KB | |
| 2025-03-17 15:17 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 52.1 KB | |
| 2025-03-17 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 52.3 KB | |
| 2025-03-13 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 24.0 KB | |
| 2025-03-12 15:03 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 23.7 KB | |
| 2025-03-12 14:59 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 22.0 KB | |
| 2025-03-11 11:17 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 21.8 KB | |
| 2025-03-07 13:04 |
Declaration of Voting Results & Voting Rights Announcements
Result of General Meeting
|
English | 13.4 KB | |
| 2025-03-04 13:00 |
Directors' Dealings
Director/PDMR Shareholding
|
English | 23.4 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Molecular Partners AG | Switzerland | MOLN | |
|
MorphoSys AG | Germany | MOR | |
|
MPH Health Care | Germany | 93M1 | |
|
NATAC | Spain | NAT | |
|
Navamedic | Norway | NAVA | |
|
Newbury Pharmaceuticals AB | Sweden | NEWBRY | |
|
New Nordic Healthbrands AB | Sweden | NNH | |
|
Nicoccino Holding AB | Sweden | NICO | |
|
Nicox S.A. | France | COX | |
|
Novartis AG | Switzerland | NOVN |